2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• X-linked lymphoproliferative disease 1 (XLP1) is a monogenic disorder caused by SH2D1A mutations, leading to signaling lymphocyte activation molecule (SLAM)-associated protein (SAP) absence or dysfunction.
• This dysfunction alters the function of SLAM receptors like 2B4 (CD244) and NTB-A (SLAMF6), causing immune dysregulation.
• XLP1 patients exhibit impaired NK and T cell cytotoxicity against EBV-infected B cells, resulting in severe clinical manifestations such as hyperinflammation and lymphoma.

Purpose of the Study:

• To investigate the interplay between the inhibitory receptor 2B4 and various activating receptors in Natural Killer (NK) cells.
• To elucidate the mechanisms by which 2B4 engagement affects NK cell receptor signaling.
• To understand the role of inhibitory 2B4 in NK cell education and autoreactivity in XLP1 patients.

Main Methods:

• Analysis of NK cell receptor interactions, focusing on 2B4 and its downstream signaling pathways.
• Examination of the effects of 2B4 engagement on ITAM-dependent activating receptors (NCR, CD16) and other activating receptors (NKG2D, DNAM-1).
• Assessment of NK cell education and autoreactivity in XLP1 patients, including the characterization of NK cells lacking self-HLA specific inhibitory receptors.

Main Results:

• 2B4 engagement selectively inhibits ITAM-dependent activating receptors, including NCR and CD16, while sparing NKG2D and DNAM-1.
• Inhibitory 2B4 plays a crucial role in NK cell education.
• XLP1 patients harbor a significant population of functional NK cells lacking self-HLA specific inhibitory receptors, exhibiting autoreactivity against mature dendritic cells.

Conclusions:

• The findings reveal a specific inhibitory mechanism of 2B4 on certain NK cell activating receptors in the context of XLP1.
• Inhibitory 2B4 is integral to NK cell education, and its dysfunction in XLP1 leads to altered NK cell populations and potential autoreactivity.
• Understanding these interactions is critical for developing therapeutic strategies for XLP1 and related immune disorders.